1. Home
  2. ASMB vs SQNS Comparison

ASMB vs SQNS Comparison

Compare ASMB & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$36.00

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$6.08

Market Cap

85.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
SQNS
Founded
2005
2003
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
553.6M
85.3M
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
ASMB
SQNS
Price
$36.00
$6.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$43.40
$21.33
AVG Volume (30 Days)
136.8K
199.9K
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,191,000.00
$31,534,000.00
Revenue This Year
$42.01
N/A
Revenue Next Year
N/A
$70.05
P/E Ratio
N/A
N/A
Revenue Growth
31.30
3.20
52 Week Low
$7.75
$5.02
52 Week High
$39.71
$58.30

Technical Indicators

Market Signals
Indicator
ASMB
SQNS
Relative Strength Index (RSI) 58.78 45.49
Support Level $35.05 $6.17
Resistance Level $38.82 $6.98
Average True Range (ATR) 1.91 0.43
MACD -0.31 0.08
Stochastic Oscillator 46.00 39.75

Price Performance

Historical Comparison
ASMB
SQNS

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

Share on Social Networks: